Abstract:Poor tumor specificity is one of the key obstacles for clinical applications of nanotheranostic agents, consequently leading to serious side effects and unsatisfactory therapeutic efficacy. Herein, biomolecule-based nanohybrids (named as Hb-PDA-GOx) with multiple stimuli-responsiveness were designed and fabricated to enhance tumor-specific therapy. The nanohybrids embodied two proteins, i.e., hemoglobin (Hb) and glucose oxidase (GOx), which exhibited cascade catalytic activity selectively within the tumor microenvironment (TME). Specifically, GOx catalyzes the overexpressed glucose into gluconic acid and hydrogen peroxide (H2O2), which not only initiated starvation therapy (ST) through cutting off the nutrition supply for carcinoma cells, but also provided H2O2 for sequential Fenton reaction induced by Hb that generating biotoxic hydroxyl radicals (•OH) for chemodynamic therapy (CDT). Moreover, localized heat generation from polydopamine (PDA) in the nanohybrids can implement photothermal therapy (PTT) and reinforce the CDT efficacy. Excitingly, effective eradication of solid tumors and significant suppression of metastatic tumors growth were achieved by utilizing Hb-PDA-GOx as a versatile theranostic agent. All these results had been verified by in vitro and/or in vivo experiments. In light of the superior anticancer effects and insignificant systemic toxicity, the as-fabricated biomolecule-based nanohybrids could be employed as a promising agent for tumor-specific therapy. More importantly, the high biocompatibility and biodegradability of the selected biomolecules would facilitate subsequent clinical translation.Statement of significance(1) A facile one-pot synthesis strategy was proposed to fabricate biomolecule-based tumor theranostic agent with high biocompatibility and biodegradability, which would facilitate subsequent clinical translation; (2) The as-developed theranostic agent was endowed with multiple stimuli-responsiveness for achieving tumor-specific and cascade-enhanced synergistic therapy; (3) The in vivo experiments demonstrated that the as-developed theranostic agent can not only effectively eradicate solid tumors, but also significantly suppress metastatic tumors growth.

Learning from Human Metabolism for Nanomedicine: a Convertible Bismuth-Agent for Tumour-Selective Theranostics.

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

How Do Bismuth-Based Nanomaterials Function as Promising Theranostic Agents for the Tumor Diagnosis and Therapy?

Functionalization of bismuth sulfide nanomaterials for their application in cancer theranostics

A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours

Codoping Enhanced Radioluminescence of Nanoscintillators for X-Ray-Activated Synergistic Cancer Therapy and Prognosis Using Metabolomics.

Engineering Thio-/seleno-ether Linkers into Zwitterionic Small Molecule Nano-prodrugs for Traceable Cancer Theranostics

Multifunctional Bismuth Selenide Nanocomposites for Antitumor Thermo-Chemotherapy and Imaging

Responsive Degradable Theranostic Agents Enable Controlled Selenium Delivery to Enhance Photothermal Radiotherapy and Reduce Side Effects

99mTc-conjugated manganese-based mesoporous silica nanoparticles for SPECT, pH-responsive MRI and anti-cancer drug delivery.

Biomolecule-based stimuli-responsive nanohybrids for tumor-specific and cascade-enhanced synergistic therapy

"One stone, two birds": engineering 2-D ultrathin heterostructure nanosheet BiNS@NaLnF<sub>4</sub> for dual-modal computed tomography/magnetic resonance imaging guided, photonic synergetic theranostics

A Tumor Microenvironment-Responsive Theranostic Agent for Synergetic Therapy of Disulfiram-Based Chemotherapy and Chemodynamic Therapy.

From Biology To Biology: Hematoporphyrin-Melanin Nanoconjugates With Synergistic Sonodynamic-Photothermal Effects On Malignant Tumors

Two-Stage Targeted Bismuthene-Based Composite Nanosystem for Multimodal Imaging Guided Enhanced Hyperthermia and Inhibition of Tumor Recurrence

Multifunctional molecular theranostic agent for fluorescence-magnetic resonance dual-modal imaging and photodynamic-chemodynamic synergistic therapy

A cation-exchange controlled core-shell MnS@Bi 2 S 3 theranostic platform for multimodal imaging guided radiation therapy with hyperthermia boost.

Recent advances in nanomedicine for metabolism-targeted cancer therapy

Defect-engineered Transition Metal Hydroxide Nanosheets Realizing Tumor-Microenvironment-responsive Multimodal-Imaging-guided NIR-II Photothermal Therapy.

Tumor microenvironment responsive theranostic agent for enhanced chemo/chemodynamic/photothermal therapy

"Transformed" Fe3S4 Tetragonal Nanosheets: a High-Efficiency and Body-Clearable Agent for Magnetic Resonance Imaging Guided Photothermal and Chemodynamic Synergistic Therapy.